In this time of emergency, AIVD Biotech has developed the highest quality recombinant 2019-nCoV antigens (Nucleocapsid Protein and Spike proteins) for rapid COVID-19 antibody assays to equip healthcare workers for rapid COVID-19 antibody detection.
Antigens can be used for total antibody detection of SARS-CoV-2 virus and have been validated in Lateral Flow and ELISA with clinical serum samples with high sensitivity and specificity.
SARS-CoV-2 Spike Proteins for Rapid COVID-19 Antibody Assays
